N@N

IMMU, BSRR, JCDA, TRIB, CRTX, JRN Are Seasonally Ripe To Go Down In the Next Five Weeks

June 20, 2012 / M2 PRESSWIRE / BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of IMMUNOMEDICS INC (NASDAQ:IMMU), SIERRA BANCORP (NASDAQ:BSRR), JACADA LTD (NASDAQ:JCDA), TRINITY BIOTECH PLC-SPON ADR (NASDAQ:TRIB), CORNERSTONE THERAPEUTICS INC (NASDAQ:CRTX), JOURNAL COMMUNICATIONS, INC. (NYSE:JRN) and each have a high seasonal probability to go Down in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at: http://www.squeezetrigger.com/services/strat/mh.php

The following stocks are expected to go Down:

  Symbol  Company                          Expected Return  Odds                 By The Following Date
  IMMU    IMMUNOMEDICS INC                 -4.14%           75.00% (9 of 12)     Thursday, June 21st 2012
  BSRR    SIERRA BANCORP                   -5.85%           81.82% (9 of 11)     Tuesday, July 3rd 2012
  JCDA    JACADA LTD                       -11.68%          91.67% (11 of 12)    Thursday, August 2nd 2012
  TRIB    TRINITY BIOTECH PLC-SPON ADR     -8.08%           75.00% (9 of 12)     Thursday, August 2nd 2012
  CRTX    CORNERSTONE THERAPEUTICS INC     -7.11%           87.50% (7 of 8)      Friday, July 27th 2012
  JRN     JOURNAL COMMUNICATIONS, INC.     -8.58%           100.00% (8 of 8)     Wednesday, July 18th 2012

IMMUNOMEDICS INC (NASDAQ:IMMU) - Immunomedics, Inc. engages in the research, development, manufacture, and marketing of monoclonal antibody-based products for the treatment of cancer, and autoimmune and other serious diseases. Its products include epratuzumab, a Phase III clinical trail product for the treatment of systemic lupus erythematosus and non-Hodgkins lymphoma; Veltuzumab, a Phase I/II clinical study product for the treatment of patients with non-Hodgkins lymphoma, immune thrombocytopenic purpura, and chronic lymphocytic leukemia; Yttrium Y 90 Clivatuzumab tetraxetan, a humanized monoclonal antibody for pancreatic cancer that is in Phase Ib clinical trail; and Yttrium Y 90 epratuzumab tetraxetan, a Phase I/II clinical study product for patients with non-Hodgkins lymphoma. The companys preclinal trial products comprise Milatuzumab, a transmembrane protein product for antibody-drug immunoconjugate therapy; and Labetuzumab, a product candidate that targets colon, rectum, breast, lung, and other solid tumors. In addition, the company markets and sells a diagnostic product, LeukoScan, which is used to treat infection and inflammation in bones for patients with suspected osteomyelitis, including patients with diabetic foot ulcers. It also develops Dock-and-Lock method technology that combines conjugation chemistry and genetic engineering to enable the creation of novel human therapeutics, and the construction of enhanced recombinant products. The company distributes its products in the United States, Europe, and Japan. Immunomedics has a license and collaboration agreement with Nycomed GmbH to develop, manufacture, and commercialize veltuzumab in the subcutaneous formulation for the treatment of various non-cancer indications; and a partnership and cross-licensing agreement with Alexis Biotech Ltd. to develop vaccines against melanoma and chronic lymphocytic leukemia, and infectious diseases, such as AIDS. The company was founded in 1982 and is headquartered in Morris Plains, New Jersey.

SIERRA BANCORP (NASDAQ:BSRR) - Sierra Bancorp operates as the bank holding company for Bank of the Sierra that offers retail and commercial banking services in the central and southern sections of the San Joaquin Valley in California. Its deposit products include checking, interest-bearing transaction, savings, money market demand, time deposit, retirement, and sweep accounts, as well as remote deposit capture facilities. The companys loan portfolio comprises real estate, commercial, and agricultural loans, as well as land acquisition and development loans, construction loans for residential and commercial development, and multifamily credit facilities; small business administration (SBA) loans; equipment leasing, such as direct finance and operating leases; and retail lending services, which include home equity lines and consumer loans. In addition, it offers secondary market services, installment note collection services, cashiers checks, travelers checks, gift cards, bank-by-mail services, night depository services, safe deposit boxes, direct deposit and automated payroll services, electronic funds transfers, online banking services, ATMs, and other customary banking services. As of January 25, 2010, the company operated 24 branch offices, an agricultural credit center, an SBA center, and an online virtual branch. Sierra Bancorp has a strategic alliance with Investment Centers of America, Inc. to provide non-deposit investment options. The company was founded in 1977 and is headquartered in Porterville, California.

JACADA LTD (NASDAQ:JCDA) - Jacada Ltd., incorporated in December 1990, develops, markets and supports software and solutions that help customers simplify and improve critical business processes without the need for long and expensive system replacement projects. The Company's traditional products enable businesses to Web enable, modernize and integrate their existing software applications to serve the needs of their users, customers and partners. Its products, Jacada Fusion and Jacada Workspace, simplify the desktop of the customer service representatives. Jacada's solutions are designed to provide customers with a simplified interaction to improve the efficiency of the user and the experience of the user's customer.

Jacada Interface Server

Jacada Interface Server generates graphical user interfaces for mainframe and midrange software applications without requiring any change to the host applications. By generating Java or hyper text markup language (HTML) graphical interfaces, Jacada Interface Server enables the Company's customers to extend their host-centric applications and data to the Internet and their intranets without rewriting these applications. In addition, Jacada Interface Server provides the modern graphical features that users expect from applications. Jacada Interface Server also allows customers to enhance their applications to add functionality, integrate with other data sources and link to other Internet applications.

Jacada HostFuse

Jacada HostFuse is a software solution for integrating core host-centric business systems, including the data and processes in those systems, with multiple-packaged applications, frameworks and client environments. The Company has established sales and marketing relationships in relation to its traditional market with Siebel Systems, Computer Associates, Oracle and BEA to utilize Jacada HostFuse, where a real-time, non-intrusive solution is required to integrate a host-centric application with its customer relationship management (CRM) or enterprise application integration (EAI) solutions. Jacada's customers get the benefits of online, real-time integration with back office applications without rewriting any of their existing systems.

Jacada Fusion

Jacada Fusion is a bundling of three Jacada products: Jacada HostFuse, Jacada WinFuse and Jacada WebFuse. Jacada Fusion is a non-invasive integration platform, which can automate processes that involve different kinds of business application, whether traditional legacy green screen mainframe applications, Windows client/server applications or newer Web-based (browser-based) applications.

Jacada WinFuse

Jacada WinFuse is a non-invasive integration solution that allows companies to Web enable and integrate their Microsoft Windows and client/server applications without modifying or changing anything in the existing application. Jacada WinFuse enables organizations to leverage their existing Windows client/server applications to automate business processes and integrate and transfer data from one application to another. Jacada WinFuse can work with almost any 32-bit Windows application.

Jacada WinFuse Web service enables Windows client/server applications. Without changing anything in the original application, and without needing to access the source code, Jacada WinFuse enables organizations to automate interactions with their applications and drive the system as a user would, navigating a series of Windows forms, and inserting or retrieving data as required. Jacada WinFuse exposes these interactions as Web services that can be integrated into any Java 2 Enterprise Edition (J2EE) or .NET composite application.

Jacada WebFuse

Jacada WebFuse is a non-invasive solution for accessing and managing any HTML-based Web application, for the purpose of integrating the data and processes in the application with other business processes. Jacada WebFuse offers an approach to integrating with Web applications by using the Web application user interface to encapsulate the processes and data into Web services, which can then be integrated wi

TRINITY BIOTECH PLC-SPON ADR (NASDAQ:TRIB) - Trinity Biotech plc acquires, develops, manufactures, distributes, and sells diagnostic test kits and instrumentation worldwide. The company offers clinical laboratory products, including diagnostic tests and instrumentation, which detect infectious diseases, sexually transmitted diseases, and autoimmune disorders. It also sells raw materials to the life sciences industry. In addition, the company offers point of care diagnostic tests, which are carried out in the presence of the patient, principally to diagnose the presence of HIV antibodies in the patient. Its customers include hospitals, clinical laboratories, commercial reference laboratories, and research institutions. Trinity Biotech plc sells its products directly, as well as through distributors and strategic partners. The company was founded in 1992 and is headquartered in Bray, Ireland.

CORNERSTONE THERAPEUTICS INC (NASDAQ:CRTX) - Cornerstone Therapeutics Inc., a specialty pharmaceutical company, engages in the acquisition, development, and commercialization of branded and generic pharmaceuticals for the respiratory and related markets primarily in the United States. It offers a line of products, including CUROSURF, an natural lung surfactant, for the treatment of respiratory distress syndrome in premature infants; FACTIVE, a fluoroquinolone with an activity against certain microorganisms implicated in respiratory infections, such as multi-drug resistant strains of Streptococcus pneumoniae; SPECTRACEF, a cephalosporin for the treatment of respiratory and skin infections; and ZYFLO CR, a leukotriene synthesis inhibitor, for prophylaxis and chronic treatment of asthma. The company also markets ALLERX dose pack products that are prescribed for the treatment of symptoms of allergic rhinitis; and HYOMAX family of products, which may be prescribed for functional intestinal disorders to reduce symptoms such as those seen in mild dysenteries, diverticulitis and irritable bowel syndrome. In addition, it develops cough/cold product candidates comprising CRTX 067, CRTX 069, CRTX 072, and CRTX 074; allergy product candidates consisting of CRTX 058 and CRTX 070; CRTX 073, an anti-asthma product candidate; and anti-infective product candidates, including CRTX 062 and CRTX 068. The company is headquartered in Cary, North Carolina. As of December 31, 2009, Cornerstone Therapeutics Inc. operates as a subsidiary of Chiesi Farmaceutici S.p.A.

JOURNAL COMMUNICATIONS, INC. (NYSE:JRN) - Journal Communications, Inc., through its subsidiaries, operates as a media and communications company in the United States. The company operates in three segments: Publishing, Broadcasting, and Printing Services. The Publishing segment primarily consists of its daily newspaper, the Milwaukee Journal Sentinel, which is distributed primarily by independent contract carriers throughout southeastern Wisconsin. It also owns and operates community newspapers and shoppers in Wisconsin and Florida, as well as publishes niche publications that appeal to certain advertisers and readers. The Broadcasting segment operates 33 radio stations and 13 television stations in 12 states, as well as involves in the operation of a television station under a local marketing agreement. The Printing Services segment offers a range of commercial printing services, including printing of publications, professional journals, and documentation material. The company also operates various Web sites that provide editorial and advertising content, including JSOnline.com, MilwaukeeMarketplace.com, Milwaukeemoms.com, PackerInsider.com, and JobNoggin.com, as well as the MyCommunityNOW family of 26 community Web sites. Journal Communications, Inc. was founded in 1882 and is headquartered in Milwaukee, Wisconsin.

SqueezeTrigger.com has built a massive database that collects, analyzes and publishes multiple proprietary trading strategies that predict price moves in stocks, commodities and currencies. The data has then been integrated into an automated trading platform which can be used to connect to a live online broker and automate your trading of each of the strategies highlighted. It is extremely powerful with lightening fast execution at a very low price. Both the trading software and SqueezeTrigger data feed are available at http://www.squeezetrigger.com

www.squeezetrigger.com monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements".

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO.

INVESTMENTS & TRADING

SqueezeTrigger -- 25 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.

GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.

About SQUEEZETRIGGER.COM

WWW.SQUEEZETRIGGER.COM is a service designed to help bonafide shareholders of publicly traded US companies fight short selling. SqueezeTrigger.com has built a proprietary database that uses Threshold list feeds and short sale time and sale data from NASDAQ, AMEX and NYSE to generate detailed and useful information to combat the short selling problem. For the first time, actual trade by trade data is available to the public that shows the attempted size, actual size, price and average value of short sales in stocks that have been shorted. This information is valuable in determining the precise point at which short sellers go out-of-the-money and start losing on their short trades.

SQUEEZETRIGGER.COM has built a massive database that collects, analyzes and publishes a proprietary SqueezeTrigger for each stock that has been shorted. The SqueezeTrigger database of nearly 2.5 billion short sale transactions goes back to January 1, 2005 and calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005 because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like SqueezeTrigger.com to access the data.

The SqueezeTrigger database collects individual short trade data on over 7,000 NYSE, AMEX and NASDAQ stocks and general short trade data on nearly 8,000 OTCBB and PINKSHEET stocks. Each month the database grows by approximately 50,000,000 short sale transactions and provides investors with the knowledge necessary to time when to buy and sell stocks with outstanding short positions. By tracking the size and price of each montha'a"s short transactions, SQUEEZETRIGGER.COM provides institutions, traders, analysts, journalists and individual investors the exact price point where short sellers start losing money and a short squeeze can begin.

All material herein was prepared by SQUEEZETRIGGER.COM, based upon information believed to be reliable. The information contained herein is not guaranteed by SQUEEZETRIGGER.COM to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion.

Occassionally companies pay $995.00 to purchase data for information provided in reports issued by BUYINS.NET, a company affiliated with SQUEEZETRIGGER.COM. The data service can be cancelled at any time. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. SQUEEZETRIGGER.COM is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. SQUEEZETRIGGER.COM will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.

SQUEEZETRIGGER.COM and SQUEEZETRIGGER are intended for use by stock market professionals. As a member, visitor, or user of any kind, you accept full responsibilities for your investment and trading actions. The contents of SQUEEZETRIGGER.COM, including but not limited to all implied or expressed views, opinions, teachings, data, graphs, opinions, or otherwise are not predictions, warranty, or endorsements of any kind. Please seek stock market advice from the proper securities professional, or investment advisor.

By visiting SQUEEZETRIGGER.COM or using any data or services, you agree to assume full responsibility for the decisions or actions that you undertake. Global Automated Trading Systems, LLC, its owner(s), operators, employees, partners, affiliates, advertisers, information providers and any other associated person or entity, shall under no circumstances be held liable to the user and/or any third party for loss or damages of any kind, including but not limited to trading losses, lost trading opportunity, direct, indirect, consequential, special, incidental, or punitive damages. As a user, you agree that any damages collected shall not exceed the amount paid to SQUEEZETRIGGER.COM and/or its owners. As a website user, you agree that any and all legal matters of any kind are to be reviewed and handled in their entirety within the State of California only. By using the services of this website, you are consenting to the terms as outlined, and forfeit all legal jurisdictions in any other State.

Past performance is not a guarantee of future outcomes. Any and all examples are hypothetical and should not be considered a guarantee or endorsement of such trading activity. SQUEEZETRIGGER.COM does not take responsibility for problems of any kind, including but not limited to issues with operations, data accuracy or completeness, contacting issues, technical issues, and timeliness. SQUEEZETRIGGER.COM places great integrity on the data collected and distributed. This information is deemed reliable, but not guaranteed. All information and data is provided "as is" without warranty or guarantee of any kind.

Please seek investment and/or trading advice, council, information or services from a securities professional. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and SQUEEZETRIGGER.COM undertakes no obligation to update such statements.

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected", "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the SEC.

Contact: Thomas Ronk, CEO www.squeezetrigger.com +1-800-715-9999 Tom@squeezetrigger.com

SqueezeTrigger is a registered trademark, Reg. No. 3,120,641